Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ZBIO: Zenas BioPharma initiated with a Buy at H.C. Wainwright Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley Disclaimer & DisclosureReport an Issue
